T4	Exp 187 195	The role
T5	Exp 199 233	the transcription factor NF-kappaB
T6	Exp 237 253	the pathogenesis
T7	Exp 318 320	We
T8	Exp 464 466	it
T9	Exp 502 508	itself
T10	Exp 435 440	which
T11	Exp 459 463	that
T12	Exp 398 433	the inhibitory subunit IkappaBalpha
T13	Exp 445 458	the advantage
T14	Exp 482 501	the diseased tissue
T15	Exp 523 547	the synovial macrophages
T16	Exp 584 586	We
T17	Exp 593 597	that
T18	Exp 598 624	the spontaneous production
T19	Exp 762 798	the main anti-inflammatory mediators
T20	Exp 824 852	the IL-1 receptor antagonist
T21	Exp 987 1009	their tissue inhibitor
T22	Exp 915 929	the production
T23	Exp 1033 1053	the rheumatoid joint
T24	Exp 1104 1129	the inflammatory response
T25	Exp 1134 1156	the tissue destruction
T26	Exp 1370 1376	itself
T27	Exp 1312 1318	either
T28	Exp 1158 1182	The adenoviral technique
T29	Exp 1254 1265	the effects
T30	Exp 1350 1369	the diseased tissue
T31	Exp 1312 1327	either cultures
R6	Coref Anaphora:T10 Antecedent:T12
R7	Coref Anaphora:T11 Antecedent:T13
R8	Coref Anaphora:T8 Antecedent:T13
R9	Coref Anaphora:T9 Antecedent:T14
R10	Coref Anaphora:T21 Antecedent:T32
R11	Coref Anaphora:T26 Antecedent:T33
T1	Protein 421 433	IkappaBalpha
T2	Protein 628 655	tumor necrosis factor alpha
T3	Protein 877 889	IkappaBalpha
T32	Exp 940 960	metalloproteinases 1
T33	Exp 1202 1226	widespread applicability
